Concepedia

Kenichi Serizawa

KS

16

Publications

480

Citations

13

H-Index

2007

Active since

Affiliations

Chugai Pharma (United States)(Current)

Tokai University

University of Toyama

Kenichi Serizawa is an author at Chugai Pharma (United States) specializing in medicine, physiology, and pharmacology.

ORCID

Top concepts

Publications per year

2007–2023

16

Publications

16

New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD

Yukio Takeshita, Susumu Fujikawa, Kenichi Serizawa et al. · Neurology Neuroimmunology & Neuroinflammation · 2021 · 85 citations · Full text

Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats

Kenichi Serizawa, Kenji Yogo, Ken Aizawa et al. · Cardiovascular Diabetology · 2011 · 64 citations · Full text

22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy

Michinori Hirata, Kenichi Serizawa, Ken Aizawa et al. · Nephrology Dialysis Transplantation · 2012 · 61 citations

Pharmacological Differences Between Static and Dynamic Allodynia in Mice With Herpetic or Postherpetic Pain

Atsushi Sasaki, Kenichi Serizawa, Tsugunobu Andoh et al. · Journal of Pharmacological Sciences · 2008 · 36 citations · Full text

Anti-IL-6 receptor antibody improves pain symptoms in mice with experimental autoimmune encephalomyelitis

Kenichi Serizawa, Haruna Tomizawa-Shinohara, Mayu Magi et al. · Journal of Neuroimmunology · 2018 · 29 citations

Rows per page

1–5 of 16